跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EVEROLIMUS-TEVA everolimus 5 mg tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
EVEROLIMUS-TEVA everolimus 5 mg tablet blister pack
Approved
STANDARD
EVEROLIMUS-TEVA everolimus 5 mg tablet blister pack
Teva Pharma Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
0d4dc4e6c781e372
Company
Teva Pharma Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
0d4dc4e6c781e372
Product Name
EVEROLIMUS-TEVA everolimus 5 mg tablet blister pack
Artg Id
277285
Artg Name
EVEROLIMUS-TEVA everolimus 5 mg tablet blister pack
Sponsor
Teva Pharma Australia Pty Ltd
Company Detail Path
/organization/teva-pharma-australia-pty-ltd
Artg Date
2017-04-20
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
0d4dc4e6c781e372
Type
Standard
Back to TGA Approvals
